Bridgewater, NJ: Cosette Pharmaceuticals, Inc
S Santoso, R Kalb, M Walka, V Kiefel, C Mueller-Eckhardt, P J Newman Triplex-forming oligonucleotides (TFOs) have been shown to bind to target DNA sequences in several human gene promoters such as the c-myc oncogene, the epidermal growth factor receptor, and the dihydrofolate reductase genes
mean dose, 1.02 g/day) compared to those who were not (124)
Despite distinct differences in the response of CRE-treated animals following irradiation, there was a similar response of glutathione-related enzymes in non-exposed groups
KPV KPVa relatively new anti-inflammatory peptideis sought out for its ability to speed up healing, curb infection, and axe chronic inflammation (26)
- ,